[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621463":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":21,"responsibleParty":37,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":10,"eligibilityCriteria":44,"healthyVolunteers":41,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":10,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"male and female subjects aged between 18 and 45 years who use PrEP",null,"male and female subjects aged between 18 and 45 years who use PrEP and who go to the dedicated clinics of the Infectious Diseases Unit of the IRCCS - University Hospital of Bologna for normal follow-up visits Patients will be treated in accordance with their normal care process and the results of the study-specific laboratory analyses provided for by this protocol will in no way influence the diagnostic-therapeutic path of the patients.",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Claudio Foschi, MD","CONTACT","+39 0512144515","claudio.foschi2@unibo.it",{"name":19,"role":15,"phone":10,"phoneExt":10,"email":20},"Leonardo Calza, MD","leonardo.calza@unibo.it",[22],{"facility":5,"status":23,"city":24,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"RECRUITING","Bologna","40138","Italy","IT",{"type":29,"coordinates":30},"Point",[31,32],11.33875,44.49381,{"lat":32,"lon":31},[35,36],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},{"name":19,"role":15,"phone":10,"phoneExt":10,"email":20},{"type":38,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100621463","study-of-the-antibiotic-resistance-profile-of-enterobacterales-isolated-from-rectal-mucosal-buffer-of-prep-subjects-100621463",false,"NCT07370948","Study of the Antibiotic-resistance Profile of Enterobacterales Isolated From Rectal Mucosal Buffer of PrEP Subjects","Inclusion Criteria:\n\n* age between 18 and 45 years\n* HIV-negative subjects undergoing an anorectal swab for Chlamydia trachomatis and Neisseria gonorrhoeae using NAAT as a normal diagnostic-assistance procedure provided for subjects using PrEP\n\nExclusion Criteria:\n\n* none","ALL","18 Years","45 Years",{"count":49,"type":50},200,"ESTIMATED","OBSERVATIONAL","The importance of the study lies mainly in expanding knowledge of the phenomenon of antibiotic resistance in subjects using PrEP, studying for the first time in this population the resistance phenotype in commensal Enterobacterales of the gastrointestinal tract.\n\nThe data obtained from this study could pave the way for potential surveillance and awareness programs for the critical and conscious use of antimicrobials in PrEP subjects in order to mitigate the problem of antibiotic resistance, which currently represents a real global challenge.",[54],"Infection","2026-01-22",{"date":57,"type":58},"2026-01-27","ACTUAL",{"date":60,"type":58},"2025-05-30",{"date":62,"type":50},"2026-02-28",{"name":5,"class":6},1]